Carfilzomib In Combination With Bendamustine And Dexamethasone In Refractory Or Relapsed Multiple Myeloma

NCT02056756 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

63

Enrollment

NETWORK

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Carfilzomib

Sponsor

Stichting European Myeloma Network

Collaborators

[object Object]